TotalSeq™-B1509 anti-human Bcl11b Antibody, Bcl11b, W17189A,BioLegend,384505

Host

Rat

Reactivity

Human

Application

ICPG - Quality tested

Platform ID

BAB892884527

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-B1509 anti-human Bcl11b Antibody, Bcl11b, W17189A
Cat. No.384505
HostRat
RRIDAB_3699033 (BioLegend Cat. No. 384505)
IsotypeRat IgG2a, κ
ReactivityHuman
ApplicationICPG - Quality tested
ClonalityMonoclonal
Clone NumberW17189A
Concentration0.5 mg/mL
TargetBcl11b
ImmunogenRP 1-250 (generated byE. coli)
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

The transcription factor, Bcl11b, is expressed in the thymus, mainly T cells. It is indispensable for T lineage development. When Bcl11b was deleted, T cells from all developmental stages acquired NK cell properties and concomitantly lost or decreased T cell-associated gene expression. These induced T-to-natural killer (ITNK) cells, which were morphologically and genetically similar to conventional NK cells, killed tumor cellsin vitro, and effectively prevented tumor metastasisin vivo. Therefore, ITNKs may represent a new cell source for cell-based therapies.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.